Form 4: Accelerate Diagnostics CEO Exercises Stock Options, Sells Shares to Cover Taxes
SEC Form 4 Filing
CEO Jack Phillips of Accelerate Diagnostics exercised stock options and sold shares to cover tax obligations related to vesting restricted stock units.
Summary
- On April 12, 2024, Jack Phillips, CEO of Accelerate Diagnostics, exercised 59,928 restricted stock units (RSUs) that vested.
- These RSUs were part of a grant of 119,856 RSUs awarded on March 5, 2024, with 50% vesting on April 12, 2024, and the remaining 50% vesting on April 17, 2024.
- Each RSU represents the right to receive one share of Accelerate Diagnostics common stock upon vesting.
- Phillips also sold 26,545 shares of common stock at a price of $0.86 per share on April 12, 2024.
- This sale was to cover tax withholding obligations associated with the vesting and settlement of the RSUs and was not a discretionary transaction.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock transactions by an executive. It doesn't contain information that would significantly impact investor sentiment positively or negatively.
Industry Context
This is a routine filing related to executive compensation and tax obligations. It's common for executives to sell shares acquired through stock options or RSUs to cover taxes.
Stakeholder Impact
- The sale of shares by the CEO could have a minor, temporary impact on the stock price.
Key Dates
| Date | Description |
|---|---|
| March 5, 2024 | Reporting person was granted a total of 119,856 restricted stock units ('RSUs') |
| April 12, 2024 | CEO exercised 59,928 RSUs and sold 26,545 shares to cover tax obligations. |
| April 17, 2024 | Remaining 50% of the 119,856 RSUs vest. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.